What a Survey Can't Ask
There are three ways to find out what Sjögren's does to a person's life, and this year all three produced an answer at roughly the same time.
The Sjögren's Foundation asked patients directly. Its “Living with Sjögren's” survey drew more than 6,000 detailed responses covering symptoms, diagnosis, and daily life. A dataset that large and that specific doesn't happen without a great deal of careful work, and it gives patients hard numbers for things they have been saying about this disease for years.
Nearly a third of respondents waited five or more years for a diagnosis. Fatigue, not dryness, was named most often as the symptom with the greatest impact on daily life. Eighty-one percent said Sjögren's gets in the way of the things they need to do each day.
Numbers like these matter. They turn "I'm exhausted all the time and no one believes me" into a documented, shared experience.
The Autoimmune Registry arrived at the same findings from a different direction. Rather than asking patients directly, the Registry works from patient-reported data in the NIH's All of Us Research Program. That means its picture of Sjögren's is assembled from what gets recorded during care. The results reveal the same cluster of problems the Foundation's respondents described: fatigue, dry eyes, dry mouth, joint stiffness and swelling, cognitive impairment, along with depression, anxiety, acid reflux, and sinus problems. They included quality-of-life measures including pain and fatigue levels, physical and mental health, relationship satisfaction, and whether people can carry out their day-to-day roles.
Two independent methods, two different vantage points, one consistent picture. That convergence is worth something on its own.
Then the Smart Patients Sjögren's community read the survey results and talked about them, and a third kind of information appeared.
The first thing members did was question a finding: Eighty percent of survey respondents had expressed confidence in their care and 82 percent felt their provider was knowledgeable about Sjögren's. One member's reaction was immediate:
"I'm surprised that satisfaction with their rheumatologist ranked so high."
What followed in the discussion wasn't disagreement with the number. Members described cycling through two or three specialists before finding one who understood the disease well enough to manage it. The satisfaction figure tells where people ended up. Our discussion filled in what it takes to get there.
The second thing members did was notice an absence.
Autonomic dysfunction was not among the conditions the survey asked about. Dysautonomia came up repeatedly in our community discussion, and members connected it directly to the two symptoms the survey had identified as most disruptive: fatigue and brain fog. One member put the underlying argument plainly:
"Inability to think clearly, concentrate, or remember are physical symptoms. The emotional and mental health burden can be associated with anything and everything in Sjögren's, and some patients have no issues in that area, but memory problems are a physical symptom of an underlying problem."
Members traced the mechanism as they understood it, linking cognitive symptoms to reduced blood flow to the brain, neuroinflammation, and mitochondrial dysfunction. Their point was that these are mechanical problems, not moods, and that classifying them under mental health puts them in the wrong category and sends patients toward the wrong help.
A survey returns answers to the questions it thought to ask. A registry returns what clinicians thought to record. Neither instrument can surface a symptom domain that nobody has yet connected to the disease. An open conversation among patients can, and in this case did.
The Foundation's survey tells us what is happening across thousands of patients. The Registry confirms it from the clinical record. The community tells us what neither one asked, and that is the question worth carrying into next year's survey.
Thank you to the Sjögren's Foundation for this report, to the Autoimmune Registry for the data behind it, and to the Smart Patients Sjögren's community for the conversation.